多发性硬化症中病变填充对大脑年龄估计的影响
Salem Hannoun1, Grace Fayad2, Nabil K El Ayoubi3
1Medical Imaging Sciences Program, Division of Health Professions, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon. sh156@aub.edu.lb.
BMC medical imaging
|August 27, 2025
概括
在多发性硬化症 (MS) 中,大脑年龄的估计是强大的,病变填充提供了适度的结构改善. 大脑年龄差距 (BAG) 与临床和成像标记相关,支持其在MS神经退行评估中的使用.
科学领域:
- 神经成像
- 生物标志物
- 神经退化
背景情况:
- 大脑年龄估计是多发性硬化症神经退行的一个有希望的生物标志物.
- 在大脑年龄预测模型中, 多发性硬化病变可能引发不准确性.
- 病变填充对大脑年龄估计及其临床关联的影响尚不清楚.
研究的目的:
- 评估病变填充对MS患者大脑年龄估计的影响.
- 评估大脑年龄差距 (BAG) 和临床/结构标记之间的关联.
- 确定病变填充是否改善大脑年龄估计的结构解释性和临床相关性.
主要方法:
- 使用BrainAgeR管道分析了571名复发性复发性多发性硬化症患者.
- 根据非病变填充和病变填充的T1加权图像估计的大脑年龄.
- 使用多变量线性回归计算BAG和评估与临床结果的关联 (EDSS,9HPT,SDMT,25FWT) 和体积测量.
主要成果:
- 非病变填充和病变填充的大脑年龄估计显示高一致 (r=0. 97).
- 损伤填充稍微减少了预测年龄的平均绝对误差.
- 这两种BAG测量与临床评分相关,病变填充的BAG与灰质,乳头和海马体积有更强的关联.
结论:
- 在多发性硬化中,损伤填充对大脑年龄估计的结构性解释性有所改善.
- 大脑年龄估计是MS的一个强有力的生物标志物,
- 建议在精确解释大脑年龄时进行损伤纠正.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


